Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Abroad (travel likely)RecruitingPHASE2

Conditions

Peritoneal Malignant Mesothelioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

  • Alliance for Clinical Trials in Oncology, Chicago, Illinois, United States

    Contact: Study coordinator (Aaron S. Mansfield) · mansfield.aaron@mayo.edu · 507-293-0569
    Contact: Principal Investigator (Aaron S. Mansfield)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Hedy L. Kindler)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • The Carle Foundation Hospital, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Unity Hospital, Fridley, Minnesota, United States

  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Aaron S. Mansfield)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Rice Memorial Hospital, Willmar, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Sanford Cancer Center Worthington, Worthington, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (John L. Hays)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Hassan Hatoum)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Liza C. Villaruz)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • MD Anderson in The Woodlands, Conroe, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 866-632-6789
    Contact: Principal Investigator (Kanwal P. Raghav)
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Kanwal P. Raghav)
  • MD Anderson West Houston, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Kanwal P. Raghav)
  • MD Anderson League City, League City, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Kanwal P. Raghav)
  • MD Anderson in Sugar Land, Sugar Land, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Kanwal P. Raghav)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Matthias Weiss)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
Study leads
  • Aaron S Mansfield

    Principal Investigator

    Alliance for Clinical Trials in Oncology